Media
Corgentech to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Oct 19, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that Richard P. Powers, the company's vice president and chief financial officer, will present at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference on Tuesday, October 26, 2004 at 10:50 a.m. Eastern time in New York.
To access the live webcast or the subsequent archived recording, log on to www.corgentech.com and go to the Investor Information page. Please connect to Corgentech's website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.
About Corgentech
Corgentech is a biopharmaceutical company engaged in the discovery, development and commercialization of a new class of therapeutics called transcription factor decoys, or TF decoys. We are creating a pipeline of novel therapeutics based on our proprietary TF decoy technology, focused initially on the treatment of cardiovascular disease, inflammatory disease, and cancer. For more information on the company and its technology, visit www.corgentech.com.
SOURCE Corgentech Inc.
Jennifer Cook Williams of Corgentech, +1-650-624-9600, or [email protected]; or Daryl Messinger of WeissComm Partners, +1-415-999-2361, or [email protected], for Corgentech
http://www.corgentech.com
Copyright (C) 2004 PR Newswire. All rights reserved.
News Provided by COMTEX
